trial

Online HD-tDCS Over the Left DLPFC During a Working Memory Task for Treating Negative Symptoms of Schizophrenia

NCTId NCT05582980
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 60 (actual)
Sponsored by Tri-Service General Hospital (TSGH)
Primary completion 2023-03-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
60 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2020-06-15
Primary completion
2023-03-31
Eligibility
ALL · 20 Years · 65 Years

Interventions & indications

Drugs
HD-tDCS

Sponsors

Tri-Service General Hospital (TSGH)Lead Sponsor

Investigators

1
Hsin-An Chang, M.D.Principal Investigator

Sites

1 total
Taipei, Taiwan

Facts & assertions

4 sourced
Enrollment
60
Phase
NA
Primary Completion Date
2023-03-31
Status
COMPLETED
relationships
The graph out of here
drug
HD-tDCS
drug
lead_sponsor
Tri-Service General Hospital (TSGH)
company
indication
Negative Symptoms in Schizophrenia
indication
Schizoaffective Disorder, Mixed Type
indication
Psychotic Disorders
indication
investigator
Hsin-An Chang, M.D.
person